The landscape of medical weight loss has undergone a genuine transformation in the past several years. The emergence of GLP-1 receptor agonist medications—most prominently semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)—has produced weight loss results that were previously achievable only with bariatric surgery. At The Med Spa on Augusta in Greenville, SC, we offer physician-supervised medical weight loss programs incorporating these FDA-approved injectable medications for appropriate candidates who want meaningful, sustainable weight loss supported by medical expertise.
What Are GLP-1 Receptor Agonists?
GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications originally developed for the management of type 2 diabetes. Researchers discovered that patients taking these medications for blood sugar control also experienced significant and sustained weight loss—and clinical trials specifically for obesity demonstrated impressive results that led to FDA approval for chronic weight management.
These medications work through several complementary mechanisms:
- Slowing gastric emptying—food stays in the stomach longer, increasing and prolonging the feeling of fullness
- Reducing appetite—acting on appetite centers in the brain to decrease hunger signals
- Improving insulin sensitivity and blood sugar regulation
- Reducing cravings and the reward response to food
The practical result is that patients on GLP-1 medications experience less hunger, feel full sooner, and are less preoccupied with food—making caloric reduction easier and more sustainable than willpower-based approaches alone.
What Weight Loss Results Are Realistic?
Clinical trials have demonstrated impressive weight loss outcomes. Patients on semaglutide (Wegovy) lost an average of approximately 15 percent of their body weight over 68 weeks in pivotal clinical trials. Tirzepatide (Zepbound) trials showed average weight loss of up to 22 percent of body weight. These are averages—individual results vary—but they represent a meaningful advance over previous non-surgical weight loss options.
Who Is a Good Candidate for Medical Weight Loss With GLP-1 Medications?
FDA approval criteria for GLP-1 medications for weight management include:
- BMI of 30 or greater (obesity)
- BMI of 27 or greater (overweight) with at least one weight-related health condition such as type 2 diabetes, hypertension, or high cholesterol
Ideal candidates are also committed to lifestyle changes—medication works best in conjunction with dietary improvement and physical activity, not as a replacement for them. Our team at The Med Spa on Augusta evaluates each patient’s health history, current medications, and goals to determine whether these medications are appropriate.
The Medical Weight Loss Program at The Med Spa on Augusta
Our medically supervised program provides more than just a prescription. Patients receive ongoing monitoring including vital signs, weight, and body composition tracking; nutritional guidance tailored to support muscle preservation during weight loss; regular check-ins to adjust dosing as needed; and integration with other aesthetic services—because patients who lose significant weight often develop interest in body contouring, skin tightening, or injectables as they approach their goal.
What About Weight Regain After Stopping Medication?
Clinical data indicates that patients who discontinue GLP-1 medications tend to regain a significant portion of their lost weight over the following year. This has led to the understanding that for many patients, these medications function more like a long-term treatment than a short course—similar to medications for blood pressure or cholesterol. Individual plans vary and are discussed in detail during the consultation.
The Med Spa on Augusta provides medical weight loss programs to patients in Greenville, Anderson, Spartanburg, and the surrounding Upstate South Carolina region. To discuss your candidacy, schedule a consultation at themedspaonaugusta.com.